1.34
0.04 (3.08%)
0.04 (3.08%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 490,348 |
|
|||||
| News | - | ||||||
| Day High | 1.35 | Low High |
|||||
| Day Low | 1.26 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Zynerba Pharmaceuticals Inc | ZYNE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.04 | 3.08% | 1.34 | 16:50:04 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.34 | 1.26 | 1.35 | 1.31 | 1.30 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,896 | 490,348 | $ 1.31 | $ 643,645 | - | 0.8361 - 4.6499 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:57:38 | 1 | $ 1.28 | USD |
Period:
Draw Mode:
Zynerba Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 60.12M | 44.86M | 42.95M | $ - | $ - | -0.93 | -1.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 424.66k | 6.90% |
Zynerba Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ZYNE Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.19 | 1.39 | 1.17 | 1.25 | 638,472 | 0.15 | 12.61% |
| 1 Month | 1.14 | 1.39 | 1.09 | 1.20 | 488,568 | 0.20 | 17.54% |
| 3 Months | 1.01 | 1.60 | 0.89 | 1.19 | 580,757 | 0.33 | 32.67% |
| 6 Months | 2.65 | 2.83 | 0.8361 | 1.45 | 448,024 | -1.31 | -49.43% |
| 1 Year | 4.44 | 4.6499 | 0.8361 | 3.31 | 957,154 | -3.10 | -69.82% |
| 3 Years | 10.75 | 12.51 | 0.8361 | 4.75 | 1,318,329 | -9.41 | -87.53% |
| 5 Years | 5.85 | 16.47 | 0.8361 | 6.23 | 1,146,555 | -4.51 | -77.09% |
Zynerba Pharmaceuticals Description
| Zynerba Pharmaceuticals Inc is a pharmaceutical company that is focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product pipeline consists Zygel which is a pharmaceutically-produced CBD, a non-euphoric cannabinoid, formulated as a patent-protected permeation-enhanced gel for transdermal delivery through the skin and into the circulatory system. |